HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pieter A Doevendans Selected Research

necrostatin-1

2/2015Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs.
7/2013Increasing short-term cardiomyocyte progenitor cell (CMPC) survival by necrostatin-1 did not further preserve cardiac function.
7/2012Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
7/2011MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pieter A Doevendans Research Topics

Disease

47Myocardial Infarction
02/2022 - 02/2004
45Heart Failure
10/2022 - 03/2003
25Infarction (Infarctions)
01/2020 - 09/2002
24Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 02/2002
13Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 04/2008
11Fibrosis (Cirrhosis)
01/2020 - 08/2006
11Heart Diseases (Heart Disease)
12/2018 - 02/2002
11Ischemia
01/2016 - 09/2002
10Hypertension (High Blood Pressure)
01/2022 - 01/2012
10Reperfusion Injury
01/2020 - 01/2004
9Myocardial Ischemia (Ischemic Heart Diseases)
06/2022 - 10/2003
9Inflammation (Inflammations)
11/2019 - 10/2006
8Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy)
01/2019 - 08/2007
7Thrombosis (Thrombus)
01/2019 - 02/2011
7Atherosclerosis
01/2017 - 05/2010
6Atherosclerotic Plaque (Atheroma)
01/2018 - 01/2008
6Chest Pain (Chest Pains)
01/2018 - 04/2008
6Hypertrophy
07/2007 - 03/2002
5Cardiomyopathies (Cardiomyopathy)
01/2022 - 09/2011
5Atrial Fibrillation
10/2020 - 10/2009
5Left Ventricular Dysfunction
04/2020 - 12/2010
5Cardio-Renal Syndrome
01/2019 - 11/2006
5Stroke (Strokes)
01/2019 - 05/2009
5Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2019 - 02/2005
5Pathologic Constriction (Stenosis)
10/2016 - 12/2009
5Cardiomegaly (Heart Hypertrophy)
09/2015 - 03/2002
5Necrosis
02/2015 - 03/2011
4Cardiac Arrhythmias (Arrythmia)
10/2022 - 01/2013
4Aortic Coarctation
01/2022 - 10/2019
4Chronic Renal Insufficiency
01/2019 - 12/2010
4Acute Coronary Syndrome
01/2019 - 04/2008
4Diabetes Mellitus
01/2019 - 01/2013
4ST Elevation Myocardial Infarction
10/2016 - 06/2012
4Cicatrix (Scar)
12/2014 - 10/2012
3Neoplasms (Cancer)
12/2021 - 01/2017
3Bundle-Branch Block (Fascicular Block)
01/2018 - 10/2009
3Death (Near-Death Experience)
04/2015 - 06/2012
3Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2015 - 03/2005
3Coronary Disease (Coronary Heart Disease)
03/2015 - 03/2005
3Hemorrhage
03/2014 - 06/2012
3Peripheral Arterial Disease
10/2013 - 05/2009
3Ventricular Remodeling
02/2008 - 07/2005
3Long QT Syndrome
03/2004 - 02/2002
2Cardiac Sudden Death (Sudden Cardiac Arrest)
10/2022 - 06/2015
2Ventricular Tachycardia
10/2022 - 09/2015
2Heart Rupture
06/2022 - 06/2004
2Non-ST Elevated Myocardial Infarction
02/2022 - 04/2015

Drug/Important Bio-Agent (IBA)

10omega-Chloroacetophenone (Mace)IBA
01/2018 - 06/2012
9MicroRNAs (MicroRNA)IBA
12/2021 - 07/2007
8Proteins (Proteins, Gene)FDA Link
06/2021 - 10/2009
8CalciumIBA
06/2021 - 12/2002
7TroponinIBA
02/2022 - 09/2013
7Pharmaceutical PreparationsIBA
01/2021 - 03/2004
7Biomarkers (Surrogate Marker)IBA
01/2020 - 04/2008
6GadoliniumIBA
12/2019 - 03/2014
6DNA (Deoxyribonucleic Acid)IBA
10/2009 - 01/2004
5phospholambanIBA
10/2022 - 10/2013
5Coenzyme A (CoA)IBA
01/2022 - 01/2015
5Oxygen (Dioxygen)IBA
09/2020 - 10/2008
5ErythropoietinFDA Link
01/2019 - 11/2006
5CollagenIBA
01/2018 - 02/2004
5Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2015 - 11/2006
4CytokinesIBA
01/2020 - 02/2008
4HydrogelsIBA
01/2019 - 01/2014
4AldosteroneIBA
01/2018 - 10/2011
4Toll-Like Receptors (Toll-Like Receptor)IBA
01/2017 - 01/2010
4Exenatide (Byetta)FDA Link
10/2016 - 02/2009
4Phenobarbital (Luminal)FDA Link
10/2016 - 02/2004
4Glucose (Dextrose)FDA LinkGeneric
09/2015 - 03/2005
4LipidsIBA
03/2015 - 05/2009
4necrostatin-1IBA
02/2015 - 07/2011
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2015 - 11/2008
4CalcineurinIBA
07/2006 - 03/2002
3LDL CholesterolIBA
01/2022 - 10/2013
3HDL CholesterolIBA
01/2022 - 11/2008
3Doxorubicin (Adriamycin)FDA LinkGeneric
04/2020 - 01/2017
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2020 - 06/2004
3Biological ProductsIBA
12/2017 - 05/2003
3N 30IBA
03/2016 - 02/2011
3Insulin (Novolin)FDA Link
01/2015 - 12/2003
3erucylphosphocholineIBA
01/2013 - 11/2008
3AntioxidantsIBA
09/2009 - 06/2005
2HDL LipoproteinsIBA
01/2022 - 09/2009
2Vincristine (Oncovin)FDA LinkGeneric
04/2020 - 12/2019
2Angiotensin IIIBA
01/2020 - 12/2005

Therapy/Procedure

38Therapeutics
06/2022 - 10/2003
13Percutaneous Coronary Intervention
01/2018 - 09/2006
12Cardiac Resynchronization Therapy
01/2019 - 08/2007
7Cell- and Tissue-Based Therapy (Cell Therapy)
01/2019 - 01/2007
6Stents
01/2019 - 06/2012
5Transplantation
01/2017 - 03/2003
4Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
10/2022 - 06/2015
4Heart Transplantation (Grafting, Heart)
01/2020 - 03/2014
4Transcatheter Aortic Valve Replacement
01/2016 - 05/2015
4Denervation
05/2015 - 08/2013
4Heart-Assist Devices
01/2015 - 02/2005
3Drug-Eluting Stents
01/2018 - 06/2012
3Secondary Prevention
10/2011 - 05/2009
3Cell Transplantation
08/2009 - 10/2003
2Drug Therapy (Chemotherapy)
04/2020 - 03/2011